Off 10% after company update cited some slight delay in clinical trials sign-up procedure and therefore results delayed till Q4 instead of Q3 2004.
IMO presents a buying opportunity as the impatient pass their shares to the patient
Any comments?
Add to My Watchlist
What is My Watchlist?